Skip to main content

Advertisement

Table 5 Incidence of TEAEs Associated With Discontinuation

From: Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder

  Placebo (n = 62) 30 mg/d LDX (n = 119) 50 mg/d LDX (n = 117) 70 mg/d LDX (n = 122) Active Doses (n = 358)
Discontinuation, n (%)      
   Insomnia 0 (0) 2 (1.7) 3 (2.6) 3 (2.5) 8 (2.2)
   Sleep disorder 0 (0) 0 (0) 1 (0.9) 0 (0) 1 (0.3)
   Hypersomnia 0 (0) 1 (0.8) 0 (0) 0 (0) 1 (0.3)